← Back to patent-cliff list
CAS 175711-83-8
1-(4-chloro-2-fluorophenyl)ethanone
Codes: GAND-010
Application context (from source-drug indications)
Haematological malignancyGandotinibMyelofibrosisGandotinibMyeloproliferative neoplasmGandotinibEssential thrombocythaemiaGandotinibPolycythaemia veraGandotinib
Source drugs (routes using this intermediate)
| Drug | Tier | Expiry |
|---|---|---|
| Gandotinib | Tier C — Watch / trade | - |
Position in synthesis routes (up/downstream chain)
Ordered by route registration; left → right is the synthesis direction. The highlighted node is the current CAS; others link to their own profiles.
6-chloropyridazin-3-amine→1,1-dimethoxy-N,N-dimethylethanamine→(E)-N'-(6-chloropyridazin-3-yl)-N,N-dimethylacetimidamide→2-chloro-1-(4-chloro-2-fluorophenyl)ethanone→(4-chloro-2-fluorophenyl)(6-chloro-2-methylimidazo[1,2-b]pyridazin-3-yl)methanone→(4-chloro-2-fluorophenyl)(6-chloro-2-methyl-8-(morpholinomethyl)imidazo[1,2-b]pyridazin-3-yl)methanone→4-((6-chloro-3-(4-chloro-2-fluorobenzyl)-2-methylimidazo[1,2-b]pyridazin-8-yl)methyl)morpholine→1-(tert-butyl)-3-methyl-1H-pyrazol-5-amine→3-(4-chloro-2-fluorobenzyl)-N-(1-(4-methoxybenzyl)-3-methyl-1H-pyrazol-5-yl)-2-methyl-8-(morpholinomethyl)imidazo[1,2-b]pyridazin-6-amine→1-(4-chloro-2-fluorophenyl)ethanone→tert-butylhydrazine hydrochloride→(E)-3-aminobut-2-enenitrile→3-(4-chloro-2-fluorobenzyl)-2-methyl-N-(5-methyl-1H-pyrazol-3-yl)-8-(morpholinomethyl)imidazo[1,2-b]pyridazin-6-amine
Intermediates available on this site
No listed intermediates for this target yet — send an RFQ directly and it will enter our matching pool.
This is a CAS-level registry record: registrations across routes are merged. Supplier offers and buyer demands will be matched on this CAS as the primary key.